摘要 |
A pharmaceutical composition for the treatment of allergic and inflammatory conditions with cough, such as allergic rhinitis, bronchial asthma, bronchitis, bronchiectasis, sinusitis, otitis media, pneumonia, bronchopneumonia, atelectasis by mucous obstruction or bronchoconstriction; characterized by comprising an effective amount of the non-sedating antihistamine loratadine in combination with an effective amount of the expectorant ambroxol and an acceptable pharmaceutical carrier.
|